NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) (352165)
Applications due Nov 13, 2026
The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33) invites applications for early phase clinical trials focused on natural products. This funding opportunity supports research into botanicals and dietary supplements that show promise based on preliminary evidence. Successful trials can receive up to six years of funding to enhance understanding of pharmacokinetics and clinical impacts. Applications must aim to optimize product delivery and explore innovative combinations with other treatment approaches.
US Dept. of Health & Human Services: National Institutes of Health (NIH)
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) (352163)
Applications due Nov 13, 2026
The NCCIH Natural Product Early Phase Clinical Trial Award (R33) invites applications for early phase clinical trials of natural products like botanicals and dietary supplements. This funding aims to support studies that assess the impact of these products on target engagement and clinical outcomes. The NOFO encourages innovative designs that optimize delivery methods and investigate combinations with existing treatments. With a maximum support period of three years, the initiative seeks to translate basic science findings into practical clinical applications.
US Dept. of Health & Human Services: National Institutes of Health (NIH)
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) (357493)
Applications due Nov 13, 2026
The NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) grant invites applications for mid-phase clinical trials focusing on natural products such as botanicals and dietary supplements. It aims to advance scientific knowledge by determining optimal dosing and patient responses. Applicants must provide preliminary data demonstrating bioavailability and measurable impacts on target engagement. This initiative will not support efficacy trials for cancer treatments and encourages early contact with NCCIH scientific contacts.
US Dept. of Health & Human Services: National Institutes of Health (NIH)
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) (357492)
Applications due Nov 13, 2026
The NCCIH Natural Product Early Phase Clinical Trial Award supports innovative clinical trials of natural products, such as botanicals and dietary supplements, with a strong scientific basis. Applications are encouraged to explore optimal delivery methods and combinations with other treatments. Funding is available for up to three years to assess the impact on target engagement and clinical outcomes, aiming to translate basic science findings into practical clinical applications.
US Dept. of Health & Human Services: National Institutes of Health (NIH)
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) (357490)
Applications due Nov 13, 2026
The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33) invites research proposals for early phase clinical trials of natural products, including botanicals and dietary supplements, emphasizing scientific validity for further testing. Applicants may receive up to three years of funding for pharmacokinetics and bioavailability studies, with potential for an additional three years to evaluate clinical outcomes. This initiative aims to optimize natural product delivery through innovative study designs.
US Dept. of Health & Human Services: National Institutes of Health (NIH)
Laboratory Flexible Funding Model (LFFM)
Letter of inquiry due Dec 15, 2026
The Laboratory Flexible Funding Model (LFFM) aims to enhance state food testing laboratories' capabilities, supporting an integrated food safety system. By prioritizing sample testing and food defense preparedness in microbiology, chemistry, and radiochemistry, this cooperative agreement facilitates method development and expands testing capacity, ensuring safer food for consumers.
US Department of Health & Human Services: Food and Drug Administration (FDA)
US $250,000 - US $1,000,000
Specialty Crop Multi-State Program (SCMP)
Applications due Dec 5, 2026
The California Specialty Crop Multi-State Program, established by the California Department of Food and Agriculture, aims to enhance the competitiveness of specialty crops through funding collaborative projects addressing key issues like food safety and marketing. Grants range from $250,000 to $1 million, supporting initiatives that span up to three years. This program emphasizes the importance of specialty crops, including fruits, vegetables, and horticulture, in California's agricultural landscape.
California Department of Food & Agriculture
US $50,000 - US $2,000,000
MPPEP Phase 3 Invasive Wild-Caught Catfish (363804)
Applications due Dec 8, 2026
The MPPEP Phase 3 program aims to enhance processing capabilities for invasive, wild-caught catfish, benefiting both processors and fishers. By increasing processing capacity and volume, the initiative seeks to create fair wages and stable job opportunities, fostering economic growth in rural areas. This grant will support innovative strategies that ensure sustainable practices and elevate incomes within the community, thus contributing to the overall development of the meat and poultry sector.
Rural Business-Cooperative Service